Vδ2 T细胞趋化至关节参与类风湿关节炎发病
发现RA患者外周Vδ2 T细胞显著降低且与疾病活动度负相关,Vδ2 T细胞在滑膜积聚并产生干扰素-γ和IL-17,其趋化受体CCR5和CXCR3表达升高由血清TNF-α通过NF-κB信号驱动,TNF-α中和治疗可下调CCR5和CXCR3并恢复外周Vδ2 T细胞。结论提示靶向Vδ2 T细胞可能是RA的潜在治疗途径。
要点
- RA患者外周Vδ2 T细胞显著降低,与DAS28疾病活动度负相关。
- Vδ2 T细胞在RA滑膜积聚,产生高水平的干扰素-γ和IL-17。
- TNF-α通过NF-κB信号驱动Vδ2 T细胞CCR5和CXCR3表达升高。
核心结论
- 高水平TNF-α促进RA患者Vδ2 T细胞表达CCR5和CXCR3,使其潜在浸润滑膜并在RA发病中起关键作用。
- 靶向Vδ2 T细胞可能是类风湿关节炎的潜在治疗途径。
研究设计与样本
- 所有RA患者符合2010年美国风湿病学会/欧洲抗风湿病联盟RA分类标准。
- 采用流式细胞术定量外周Vδ2 T细胞群、趋化因子受体表达和促炎细胞因子分泌。
- 采用免疫组化和流式细胞术检测滑膜中Vδ2 T细胞浸润。
- 采用流式细胞术和Transwell迁移实验测定TNF-α和IL-6对Vδ2 T细胞迁移的影响。
主要发现
- RA患者外周Vδ2 T细胞(而非Vδ1 T细胞)显著降低,且与DAS28评估的疾病活动度负相关。
- RA来源的Vδ2 T细胞在滑膜积聚并产生高水平的干扰素-γ和IL-17。
- RA来源的Vδ2 T细胞趋化潜能升高,高表达趋化因子受体CCR5和CXCR3,由血清TNF-α升高通过NF-κB信号驱动。
- 体内TNF-α中和治疗显著下调RA患者Vδ2 T细胞上的CCR5和CXCR3,并恢复外周Vδ2 T细胞。
临床怎么用
- TNF-α中和治疗可下调Vδ2 T细胞CCR5和CXCR3并恢复外周Vδ2 T细胞,支持其作为RA治疗手段的机制依据。
- 靶向Vδ2 T细胞可能成为RA的潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To explore the role of Vδ2 T cells in the pathogenesis of rheumatoid arthritis (RA). METHODS: Sixty-eight patients with RA, 21 patients with osteoarthritis and 21 healthy controls were enrolled in the study. All patients with RA fulfilled the 2010 American College of Rheumatology/European League Against Rheumatism criteria for RA. Peripheral Vδ2T population, chemokine receptor expression and proinflammatory cytokine secretion were quantified by flow cytometry. The infiltration of Vδ2 T cells within the synovium was examined by immunohistochemistry and flow cytometry. The effect of tumour necrosis factor (TNF)-α and interleukin (IL)-6 on Vδ2 T migration was determined by flow cytometry and transwell migration assay. RESULTS: Peripheral Vδ2T cells, but not Vδ1 T cells, were significantly lower in patients with RA, which was negatively correlated with disease activity gauged by Disease Activity Score in 28 joints. Vδ2 T cells from RA accumulated in the synovium and produced high levels of proinflammatory cytokines including interferon-γ and IL-17. Phenotypically, Vδ2 T cells from RA showed elevated chemotaxis potential and expressed high levels of chemokine receptors CCR5 and CXCR3, which was driven by increased serum TNF-α through nuclear factor kappa B signalling. In vivo, TNF-α neutralising therapy dramatically downregulated CCR5 and CXCR3 on Vδ2 T cells and repopulated the peripheral Vδ2 T cells in patients with RA. CONCLUSIONS: High levels of TNF-α promoted CCR5 and CXCR3 expression in Vδ2 T cells from RA, which potentially infiltrated into the synovium and played crucial roles in the pathogenesis of RA. Targeting Vδ2 T cells might be a potential approach for RA.
引用
- Mo WX, Yin SS, Chen H, et al. Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis. Ann Rheum Dis. 2017. PMID: 28866647. doi:10.1136/annrheumdis-2016-211069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。